ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 14988bc67a2bcb1f
Product Name: ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial
Artg Id: 343262
Artg Name: ENHERTU trastuzumab deruxtecan 100 mg powder for injection vial
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2021-10-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d7f5c4f9e240ba81d8a12d67fbea99cb.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/0e7e6297ed1c4a8903cd3c7bb3b90945.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

14988bc67a2bcb1f

Type

Standard